Skip to Content

Spencer Pharmaceutical Inc SPPH

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Spencer Pharmaceutical Inc specializing in the identification of new drug delivery applications and focuses on patented formulation of existing drugs from the incubation to the developmental stages or synthesized drugs to cross the blood-brain barrier.

Contact
413 Churchill Avenue
Ottawaa, ON, K1Z 5C7
T +1 613 808-0542
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Mar 31, 2004
Fiscal Year End Dec 31, 2012
Stock Type
Employees 15